CC
Corton Capital Portfolio holdings
AUM
$85.9M
1-Year Return
50.75%
This Quarter Return
+7.32%
1 Year Return
+50.75%
3 Year Return
+186.03%
5 Year Return
–
10 Year Return
–
AUM
$272M
AUM Growth
-$42.5M
(-14%)
Cap. Flow
-$55.4M
Cap. Flow
% of AUM
-20.39%
Top 10 Holdings %
Top 10 Hldgs %
27.39%
Holding
695
New
135
Increased
119
Reduced
238
Closed
202
Top Buys
| 1 |
Macy's
M
|
+$1.29M |
| 2 |
Micron Technology
MU
|
+$1.09M |
| 3 |
Lam Research
LRCX
|
+$802K |
| 4 |
eHealth
EHTH
|
+$788K |
| 5 |
Guess, Inc.
GES
|
+$722K |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$2.14M |
| 2 |
Merck
MRK
|
+$1.61M |
| 3 |
PBF Energy
PBF
|
+$1.07M |
| 4 |
Advanced Micro Devices
AMD
|
+$1.02M |
| 5 |
Viking Therapeutics
VKTX
|
+$987K |
Sector Composition
| 1 | Technology | 38.32% |
| 2 | Healthcare | 14.2% |
| 3 | Consumer Discretionary | 11.14% |
| 4 | Financials | 8.55% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Guardant Health
GH
$7.36B
| $255K | 0.09% |
+12,348
| New | +$255K |
|
327
CVR Energy
CVI
$3.31B
| $253K | 0.09% |
7,105
-11,832
| -62% | -$422K |
|
328
Revolution Medicines
RVMD
$7.65B
| $253K | 0.09% |
+7,856
| New | +$253K |
|
|
329
Viking Therapeutics
VKTX
$2.84B
| $252K | 0.09% |
3,078
-12,033
| -80% | -$987K |
|
330
Paysafe
PSFE
$839M
| $252K | 0.09% |
15,969
-6,100
| -28% | -$96.3K |
|
331
Asbury Automotive
ABG
$4.95B
| $252K | 0.09% |
+1,068
| New | +$252K |
|
|
BRDG
332
DELISTED
Bridge Investment Group
BRDG
| $250K | 0.09% |
36,506
+4,606
| +14% | +$31.6K |
|
333
Booz Allen Hamilton
BAH
$12.6B
| $249K | 0.09% |
+1,675
| New | +$249K |
|
334
Dorman Products
DORM
$4.97B
| $248K | 0.09% |
2,572
-1,758
| -41% | -$169K |
|
335
Northeast Bank
NBN
$942M
| $248K | 0.09% |
4,477
-669
| -13% | -$37K |
|
336
Realty Income
O
$54.3B
| $248K | 0.09% |
4,576
-2,758
| -38% | -$149K |
|
337
HP
HPQ
$27.3B
| $247K | 0.09% |
8,181
-15,076
| -65% | -$456K |
|
338
Select Medical
SEM
$1.63B
| $247K | 0.09% |
15,215
-628
| -4% | -$10.2K |
|
339
Castle Biosciences
CSTL
$711M
| $246K | 0.09% |
11,123
-1,220
| -10% | -$27K |
|
340
Goodyear
GT
$2.44B
| $246K | 0.09% |
17,918
-6,985
| -28% | -$95.9K |
|
341
McCormick & Company Non-Voting
MKC
$18.8B
| $246K | 0.09% |
3,202
-1,912
| -37% | -$147K |
|
342
Align Technology
ALGN
$10.1B
| $246K | 0.09% |
750
-594
| -44% | -$195K |
|
343
Amphastar Pharmaceuticals
AMPH
$1.37B
| $245K | 0.09% |
5,586
-329
| -6% | -$14.4K |
|
344
Kinsale Capital Group
KNSL
$10.4B
| $244K | 0.09% |
465
-511
| -52% | -$268K |
|
345
Ironwood Pharmaceuticals
IRWD
$185M
| $244K | 0.09% |
28,006
-6,685
| -19% | -$58.2K |
|
346
Jazz Pharmaceuticals
JAZZ
$7.78B
| $244K | 0.09% |
2,025
+88
| +5% | +$10.6K |
|
347
Chord Energy
CHRD
$5.95B
| $244K | 0.09% |
1,368
-275
| -17% | -$49K |
|
348
EyePoint Pharmaceuticals
EYPT
$975M
| $243K | 0.09% |
11,779
+268
| +2% | +$5.54K |
|
349
Graphic Packaging
GPK
$6.13B
| $243K | 0.09% |
+8,331
| New | +$243K |
|
350
Northwest Natural Holdings
NWN
$1.7B
| $241K | 0.09% |
+6,470
| New | +$241K |
|